Literature DB >> 29926176

Lack of liver steatosis in germ-free mice following hypercaloric diets.

Valentina Kaden-Volynets1, Marijana Basic2, Ulrike Neumann1, Dominik Pretz1,3, Andreas Rings1, André Bleich2, Stephan C Bischoff4.   

Abstract

PURPOSE: Experimental liver steatosis induced by overfeeding is associated with enhanced gut permeability and endotoxin translocation to the liver. We examined the role of the gut microbiota for steatosis formation by performing the feeding experiments in mice raised under conventional and germ-free (GF) housing.
METHODS: Adult wild-type and GF mice were fed a Western-style diet (WSD) or a control diet (CD), the latter combined with liquid fructose supplementation (F) or not, for 8 weeks. Markers of liver steatosis and gut permeability were measured after intervention.
RESULTS: Mice fed a WSD increased body weight compared to those fed a CD (p < 0.01) under conventional, but not under GF conditions. Increased liver weight, liver-to-body-weight ratio and hepatic triglycerides observed in both the WSD and the CD + F groups, when compared with the CD group, were not apparent under GF conditions, whereas elevated plasma triglycerides were visible (p < 0.05). Wild-type mice fed a WSD or a CD + F, respectively, had thinner adherent mucus layer compared to those fed a CD (p < 0.01), whereas GF mice had always a thin mucus layer independently of the diet. GF mice fed a CD showed increased plasma levels of FITC-dextran 4000 (1.9-fold, p < 0.05) and intestinal fatty acid-binding protein-2 (2.4-fold, p < 0.05) compared with wild-type mice.
CONCLUSIONS: GF housing results in an impaired weight gain and a lack of steatosis following a WSD. Also the fructose-induced steatosis, which is unrelated to body weight changes, is absent in GF mice. Thus, diet-induced experimental liver steatosis depends in multiple ways on intestinal bacteria.

Entities:  

Keywords:  Fructose; Germ free; Intestinal barrier; Liver steatosis; Mucin; Western-style diet

Year:  2018        PMID: 29926176     DOI: 10.1007/s00394-018-1748-4

Source DB:  PubMed          Journal:  Eur J Nutr        ISSN: 1436-6207            Impact factor:   5.614


  13 in total

Review 1.  Gut microbiota in liver disease: too much is harmful, nothing at all is not helpful either.

Authors:  Phillipp Hartmann; Huikuan Chu; Yi Duan; Bernd Schnabl
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2019-02-15       Impact factor: 4.052

2.  Impaired Chylomicron Assembly Modifies Hepatic Metabolism Through Bile Acid-Dependent and Transmissible Microbial Adaptations.

Authors:  Yan Xie; Hitoshi Matsumoto; Susan Kennedy; Elizabeth P Newberry; William Moritz; Brian J DeBosch; Kelle H Moley; Deborah C Rubin; Brad W Warner; Andrew L Kau; Phillip I Tarr; Todd N Wylie; Kristine M Wylie; Nicholas O Davidson
Journal:  Hepatology       Date:  2019-05-23       Impact factor: 17.425

Review 3.  The interaction between the gut microbiota and dietary carbohydrates in nonalcoholic fatty liver disease.

Authors:  Grace Park; Sunhee Jung; Kathryn E Wellen; Cholsoon Jang
Journal:  Exp Mol Med       Date:  2021-05-20       Impact factor: 8.718

4.  Inflammation: The Straw That Broke the NAFLD Liver!

Authors:  Reben Raeman
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2022-01-11

5.  Weight loss, insulin resistance, and study design confound results in a meta-analysis of animal models of fatty liver.

Authors:  Harriet Hunter; Dana de Gracia Hahn; Amedine Duret; Yu Ri Im; Qinrong Cheah; Jiawen Dong; Madison Fairey; Clarissa Hjalmarsson; Alice Li; Hong Kai Lim; Lorcan McKeown; Claudia-Gabriela Mitrofan; Raunak Rao; Mrudula Utukuri; Ian A Rowe; Jake P Mann
Journal:  Elife       Date:  2020-10-16       Impact factor: 8.140

6.  Germ-free mice are not protected against diet-induced obesity and metabolic dysfunction.

Authors:  Chiara H Moretti; Tomas A Schiffer; Xuechen Li; Eddie Weitzberg; Mattias Carlström; Jon O Lundberg
Journal:  Acta Physiol (Oxf)       Date:  2020-12-06       Impact factor: 6.311

7.  Active phase prebiotic feeding alters gut microbiota, induces weight-independent alleviation of hepatic steatosis and serum cholesterol in high-fat diet-fed mice.

Authors:  Shreya Ghosh; Xin Yang; Linghua Wang; Chenhong Zhang; Liping Zhao
Journal:  Comput Struct Biotechnol J       Date:  2020-12-24       Impact factor: 7.271

Review 8.  Nonalcoholic Fatty Liver Disease.

Authors:  Lingling Ding; Yvonne Oligschlaeger; Ronit Shiri-Sverdlov; Tom Houben
Journal:  Handb Exp Pharmacol       Date:  2022

9.  Dietary fructose feeds hepatic lipogenesis via microbiota-derived acetate.

Authors:  Steven Zhao; Cholsoon Jang; Joyce Liu; Kahealani Uehara; Michael Gilbert; Luke Izzo; Xianfeng Zeng; Sophie Trefely; Sully Fernandez; Alessandro Carrer; Katelyn D Miller; Zachary T Schug; Nathaniel W Snyder; Terence P Gade; Paul M Titchenell; Joshua D Rabinowitz; Kathryn E Wellen
Journal:  Nature       Date:  2020-03-18       Impact factor: 49.962

Review 10.  The role of the microbiome in NAFLD and NASH.

Authors:  Aleksandra A Kolodziejczyk; Danping Zheng; Oren Shibolet; Eran Elinav
Journal:  EMBO Mol Med       Date:  2019-02       Impact factor: 12.137

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.